Special Topics in Heterocyclic Chemistry, Volume 30 - Weissberger, Arnold; Taylor, Edward C
631,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
  • Gebundenes Buch

The Chemistry of Heterocyclic Compounds, since its inception, has been recognized as a cornerstone of heterocyclic chemistry. Each volume attempts to discuss all aspects - properties, synthesis, reactions, physiological and industrial significance - of a specific ring system. To keep the series up-to-date, supplementary volumes covering the recent literature on each individual ring system have been published. Many ring systems (such as pyridines and oxazoles) are treated in distinct books, each consisting of separate volumes or parts dealing with different individual topics. With all authors…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
The Chemistry of Heterocyclic Compounds, since its inception, has been recognized as a cornerstone of heterocyclic chemistry. Each volume attempts to discuss all aspects - properties, synthesis, reactions, physiological and industrial significance - of a specific ring system. To keep the series up-to-date, supplementary volumes covering the recent literature on each individual ring system have been published. Many ring systems (such as pyridines and oxazoles) are treated in distinct books, each consisting of separate volumes or parts dealing with different individual topics. With all authors are recognized authorities, the Chemistry of Heterocyclic Chemistry is considered worldwide as the indispensable resource for organic, bioorganic, and medicinal chemists.
Autorenporträt
Arnold Weissberger is the author of Special Topics in Heterocyclic Chemistry, Volume 30, published by Wiley. Edward Curtis Taylor, Jr. was an American chemist who designed and synthesized the chemotherapy drug pemetrexed, an inhibitor of purine biosynthesis, with grant support from the U.S. National Cancer Institute, NIH. Taylor studied for his PhD from 1946 to 1949 at Cornell University with Professor Cornelius Cain.